Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC35F4 antisense RNA 1 (SLC35F4-AS1)
- Target
- SLC35F4-AS1
- Molecular classification
- Long non-coding RNA, Antisense RNA, Non-coding RNA
01
Overview
SLC35F4 antisense RNA 1 (SLC35F4-AS1) is a long non-coding RNA (lncRNA) transcribed from the region opposite the protein-coding SLC35F4 gene. As an antisense RNA, it may regulate the expression of SLC35F4 or potentially other nearby genes through RNA-RNA interactions, epigenetic mechanisms, or post-transcriptional regulation typical of natural antisense transcripts. There is no current evidence supporting its consideration as a classic therapeutic drug target (such as a receptor, transporter, or enzyme). No disease associations, clinical biomarkers, or drug interactions are documented for SLC35F4-AS1. Its precise functional role remains uncharacterized, consistent with many lncRNAs, but the general regulatory functions of antisense RNAs include modulation of gene expression and chromatin architecture.
- Other names
- SLC35F4 antisense RNA 1
02
Mechanism of action
Not applicable (does not encode a protein and no targeting drugs are known)
03
Biological functions
Regulation of gene expression (specifically, may regulate SLC35F4 or related genes in cis or trans)Epigenetic regulation (by mechanisms typical of antisense lncRNAs)Post-transcriptional regulation (typical for antisense lncRNA families)
04
Disease associations
There is no published evidence directly linking SLC35F4-AS1 to disease as of September 2025. Antisense lncRNAs in general have been associated with various diseases such as cancer and imprinting disorders, but no specific reports for SLC35F4-AS1
Beyond the preview
Go deeper on SLC35F4 antisense RNA 1 (SLC35F4-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SLC35F4 antisense RNA 1 (SLC35F4-AS1).